Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-25-016190
Filing Date
2025-04-02
Accepted
2025-04-02 16:15:48
Documents
2
Period of Report
2025-04-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1743624940.html 3  
1 FORM 3 wk-form3_1743624940.xml 3 1625
2 EX-24 hoffmanpoa.htm EX-24 13135
  Complete submission text file 0001628280-25-016190.txt   16397
Mailing Address ARENA PHARMACEUTICALS INC 6166 NANCY RIDER DRIVE SAN DIEGO CA 92121
Business Address
Hoffman Robert E. (Reporting) CIK: 0001166288 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35986 | Film No.: 25804723

Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Issuer) CIK: 0001434868 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)